about
Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?Effects of Zinc supplementation on serum lipids: a systematic review and meta-analysisEffects of LEP G2548A and LEPR Q223R Polymorphisms on Serum Lipids and Response to Simvastatin Treatment in Chinese Patients With Primary Hyperlipidemia.Inherent suppression of thyroid stimulating hormone in newly diagnosed dyslipidemic patients - indication for use of thyromimetics?Mangiferin supplementation improves serum lipid profiles in overweight patients with hyperlipidemia: a double-blind randomized controlled trial.Efficacy of thigh volume ratios assessed via stereovision body imaging as a predictor of visceral adipose tissue measured by magnetic resonance imaging.Sleep is associated with the metabolic syndrome in a multi-ethnic cohort of midlife women: the SWAN Sleep Study.Serum lipid profiles, the prevalence of dyslipidemia and the risk factors in two isolated Chinese minorities.Use of the triglyceride to HDL cholesterol ratio for assessing insulin sensitivity in overweight and obese children in rural AppalachiaLow serum 25(OH)D levels are assocıated to hıgher BMI and metabolic syndrome parameters in adult subjects in Turkey.Dyslipidemia links obesity to early cerebral neurochemical alterationsDyslipidemia in obesity: mechanisms and potential targetsCardioprotective and anti-hypertensive effects of Prosopis glandulosa in rat models of pre-diabetesBrd2 inhibits adipogenesis via the ERK1/2 signaling pathway in 3T3-L1 adipocytesAssociations of Obesity and Dyslipidemia with Intake of Sodium, Fat, and Sugar among Koreans: a Qualitative Systematic Review.An association of metabolic syndrome constellation with cellular membrane caveolaePCSK9 and resistin at the crossroads of the atherogenic dyslipidemia.Normal weight dyslipidemia: Is it all about the liver?Dyslipidemia: Obese or Not Obese-That Is Not the Question.A Comparison of Biological and Physical Risk Factors for Cardiovascular Disease in Overweight/Obese Individuals With and Without Prediabetes.Association of change in waist circumference and dyslipidemia risk: The Rural Chinese Cohort Study.ABCA1 in adipocytes regulates adipose tissue lipid content, glucose tolerance, and insulin sensitivityAccelerated decline in renal function after acute myocardial infarction in patients with high low-density lipoprotein-cholesterol to high-density lipoprotein-cholesterol ratio.Elevated cholesteryl ester transfer protein (CETP) activity, a major determinant of the atherogenic dyslipidemia, and atherosclerotic cardiovascular disease in South Asians.Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB.Insulin resistance in Saudi postmenopausal women with and without metabolic syndrome and its association with vitamin D deficiency.Factors associated with the length of remission of psoriasis vulgaris.Hypercholesterolaemia - practical information for non-specialists.Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.The effects of the aqueous extract and residue of Matcha on the antioxidant status and lipid and glucose levels in mice fed a high-fat diet.Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients.Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?
P2860
Q26749088-9B54A51F-3755-42F3-AD72-D75D42E3CAA6Q26798492-857BCB42-7D8E-4FF7-A103-E0C3886E2522Q30277140-5F790CFB-0EA4-4523-80D5-E6F81421658CQ34479615-9905A0EF-3B8F-4CE1-8E0F-47F1D1A40CDEQ35623367-F67DFE2A-FD3B-4D7D-9810-C794EB2FE973Q35772310-A7CF2327-797D-4BBF-A63E-6A56A044B847Q35962663-6FC6B6F1-42D0-4926-83DD-0BE1E9D7A4B9Q36412184-1F820F3E-3714-4A8C-9765-8FE1C017E7F8Q36552521-E0035CCC-2304-4948-A22C-A131A8BE8E81Q36612627-880F44C3-0B95-4794-8F37-FCA468CFA1E6Q36961709-E16FD026-1390-47C5-922F-646A59266E1FQ36994072-0F006710-8C38-48C6-9213-596F4768FA8EQ37073787-1BECD60A-6D91-4B87-8DA9-7933748CADA7Q37251522-76ED07F9-5A99-4FEB-8F35-51B7F5147E7AQ37389752-50E0D806-905D-4E89-9B49-E8CE7C2B2FAFQ37589401-CE7CF596-8B59-4A69-801A-117E999D2120Q38153456-F4DC23E9-3D06-4678-890B-24C436179FC0Q38730392-C5522E0B-8708-4403-BDCD-3B5E3784B447Q38968519-FFBDF3C9-597F-4D17-96B4-14CA054F8347Q39611562-64B701D5-6568-4308-AD08-CADF5154DFCCQ40050508-1F0DED4A-E0EE-4396-B0D8-A7CD7DD992B1Q41978104-372BE05D-A60E-45B0-89E9-D14676C84B0CQ43595409-23AFD193-1887-40A9-816A-8A1D5660B2F8Q44873060-8B4BB171-DBBB-485F-B28E-F1F5C57267F6Q47109213-E8D4842C-3880-45B1-89F4-46D2B4D6D993Q47146883-18F51C2E-6945-4F93-9309-529F056ED9D2Q47686097-8499DE57-8E51-4707-A819-7A39ADEF2B04Q49592460-04041A96-AFF1-48E4-B29E-6BA19BACFC9CQ50179665-7C39B2A0-924F-41F6-B7E1-865C1C3ACF55Q50242728-3615471B-4294-4F1E-917D-31DEE3B9DB13Q53080484-35BA14BD-1B58-48ED-A55A-D9F16B59D187Q58127833-5894DABD-1B0A-44EE-991F-7FFAFBFB7D72
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Obesity and dyslipidemia.
@ast
Obesity and dyslipidemia.
@en
type
label
Obesity and dyslipidemia.
@ast
Obesity and dyslipidemia.
@en
prefLabel
Obesity and dyslipidemia.
@ast
Obesity and dyslipidemia.
@en
P2093
P1476
Obesity and dyslipidemia.
@en
P2093
Erik S G Stroes
Houshang Monajemi
John J P Kastelein
Remco Franssen
P304
P356
10.1016/J.MCNA.2011.06.003
P577
2011-09-01T00:00:00Z